Featured Stories
News Image
BOXL Gets a Fresh $7.5 Million Lifeline — Now the Real Battle for Boxlight Begins
Boxlight (NASDAQ:BOXL) secured a fresh capital lifeline, announcing the initial closing of a private placement that could provide the company with up to $7.5 million in gross proceeds while also opening a new $15 million equity line. The August 6 financing brought in $5.5 million initially, with another $2 million potentially available once a resale registration statement becomes effective. For a company that has been dealing with losses, debt obligations and Nasdaq listing pressures, the financing is about more than simply adding cash to the balance sheet: it could give Boxlight additional runway to fund operations and address debt while attempting to stabilize its business.
24-7 Market News·Aug 12, 2026, 11:57 AM
News Image
WallStreetPR Releases Report on China’s Gold Purchases and African Mining Investment

Dallas, TX, USA, August 12th, 2026, FinanceWire

financewire.com·Aug 12, 2026, 11:00 AM
News Image
These Have the Market Hot Zone Setups
Planet Green Holdings (NYSEAMERICAN:PLAG), NeOnc Technologies (NASDAQ:NTHI), and Quantum Corporation (NASDAQ:QMCO) made nice runs since our midday coverage. While AbCellera Biologics (NASDAQ:ABCL) and Bank of America (NYSE:BAC) were among the notable names reaching new 52-week highs Tuesday.
24-7 Market News·Aug 11, 2026, 7:35 PM
News Image
Enter The Market’s Hot Zone
Planet Green Holdings (NYSEAMERICAN:PLAG), Quantum Corporation (NASDAQ:QMCO), NIQ Global Intelligence (NYSE:NIQ), Fermi (NASDAQ:FRMI), WF International (NASDAQ:WXM), and NeOnc Technologies (NASDAQ:NTHI) are delivering a powerful mix of catalysts from very different corners of the market. Several are moving on developments that could reshape their stories well beyond a single trading session, while the market continues to reward companies that can connect themselves to some of the biggest themes of 2026, like  NeOnc, which heads into Wednesday with perhaps the most binary catalyst of the group: topline Phase 2a brain-cancer data that could materially alter how investors value its NEO100 program.
24-7 Market News·Aug 11, 2026, 5:14 PM
 More News